Vascular endothelium is sensitive to small changes in the plasma sodium concentration. The 'sodium sensor' is supposed to be located in the endothelium, probably closely associated with the occurrence of endothelial sodium channels [9, 11] and the negatively charged endothelial surface layer, the glycocalyx [10] .
A new perspective on evaluating the salt sensitivity in man evolved recently based on the observation that the glycocalyx of erythrocytes (red blood cells, RBC) could mimic the glycocalyx of vascular endothelium [12] . Just as in endothelium, RBC selectively bind sodium at the negatively charged surface. At extracellular sodium concentrations in the low physiological range, the remaining surface negativity is sufficient to create repulsive forces between the RBC and the vessel wall (endothelium). At high sodium concentrations, repulsive forces collapse. Then, RBC and endothelium come too close to each other. This may cause shedding of the glycocalyx, that is, damage of the RBC surface and the inner wall of the blood vessels ( fig. 1 ). In this concept, the glycocalyx serves as a 'safety cushion' between cell surfaces. The larger the cushion, the better is the buffering power for sodium. The recently developed salt blood test (SBT) is based on this concept [13] . RBC, taken from an individual by venous puncture, are suspended in two solutions of different sodium concentrations and -in presence of some other constituents to maintain constant osmolality and to render RBC 'sticky' -allowed to sediment in vertical tubes. The ratio of the respective (high over low sodium) RBC sedimentation rates gives an estimate of the individual salt sensitivity (erythrocyte sodium sensitivity, ESS).
In order to evaluate the applicability of the SBT in medical facilities outside our research laboratory, we set up a test baggage (SBT-kit; fig. 2 , inset) and sent it out to nephrologists on demand. Eight laboratories sent back their results, which are summarized in figure 2 . For analysis, the data were split into two groups, normotensive patients (no history of hypertension) and hypertensive patients (with a history of hypertension and with antihypertensive treatment). Salt sensitivity was calculated for normotensive patients (n = 13) and the mean ESS value was taken as a reference. Then, the ESS values of the hypertensive patients was calculated and related to the respective mean ESS value of the normotensive cohort. Figure 2 shows these relative values. The grey horizontal bar exhibits the standard error zone (±SEM). Columns (patients) that end in the grey bar were excluded from further analysis. It becomes obvious that out of 31 hypertensive patients, 15 individuals exert a high salt sensitivity (48%) and 10 individuals a low one (32%). This indicates that salt sensitivity in the hypertensive cohort -despite antihypertensive medication -is significantly higher as compared to the normotensive cohort ( fig. 3 a) . Further analysis revealed that both systolic and diastolic blood pressures were found significantly increased in the hypertensive cohort -despite antihypertensive treatment ( fig. 3 b, c) . Last but not the least, the body mass index (BMI) was found increased in the hypertensive cohort in relation to the normotensive one ( fig. 3 d) . However, this data lack statistical significance probably due to the low number of study participants. 
Conclusion and Outlook
The incidence of increased salt sensitivity is higher among hypertensive individuals independent of any antihypertensive therapy. However, we do not know whether the incidence of high salt sensitivity could be even higher in the absence of any antihypertensive treatment. In fact, this is likely. Although genetics could play a significant role [14] , the degree of salt sensitivity of an individual is not entirely an inherited property. As shown recently in vitro [13] and in vivo [15] , ESS values can be influenced. They are not constant values fixed over the whole life span of an individual. In other words, the glycocalyx of the vascular system does not slowly deteriorate with age (we could not find any dependence on either age or sex) but can also recover, at least to a certain extent. This view opens new strategies in the prevention and treatment of vasculopathies. The SBT could serve as a simple test system for follow-up studies giving feedback information to the treating physician and the treated patient. Finally, in a more direct way, the SBT could be useful as an assay system for testing the RBC surface quality of patients on dialysis. It should be remembered that the RBC glycocalyx 'reports' the quality of the inner vessel wall. Moreover, a 'poor' RBC glycocalyx (low sodium buffering power = high ESS value) could be probably 'recharged' (addition of negative charges?) during hemodialysis (unpublished observation of our laboratory). Such 'RBC recharge protocols' -though not yet developed -could then be tested.
